Biotech stocks are surging. How investors can play the new drug innovation boom
Source: CNBC · Oct 24, 2026
Share
The Money Angle
Business relevance
8/10
- 01Biotech shares are rising as successful clinical trials, dealmaking and new drug technologies renew investor interest.
- 02The article points to ETFs and individual stocks as ways to invest, but the supplied text names no funds or companies.
- 03No deal values, stock returns or specific implications for Black businesses or consumers are provided.
Share
Who's involved
None named
Tickers mentioned
No public companiesThis Money Angle is an AI-assisted summary of reporting by CNBC. Figures come only from the source article. Not financial advice.